68 related articles for article (PubMed ID: 11263342)
1. [TNF-alpha production and antitumor effect of rhIL-2-activated bone marrow cells].
Zhu B; Yang P; Sun B
Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):581-2. PubMed ID: 11263342
[TBL] [Abstract][Full Text] [Related]
2. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study on the lysis of leukemia cells by IL-2 activated bone marrow and cord blood].
Shi X; Yu Z; Ma R
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):417-21. PubMed ID: 15625848
[TBL] [Abstract][Full Text] [Related]
4. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
5. [Autologous dendritic cells eliciting cytotoxicity of bone marrow cells against chronic granulocytic leukemia].
Chen J; Chen Z; Wei X; Zhang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):64-7. PubMed ID: 11877050
[TBL] [Abstract][Full Text] [Related]
6. [The killing effect of IL-2 and IFN-alpha activated bone marrow on K562 leukemic cell].
Li C; Yan W; Hao Y; Feng S; Qiu L; Liu H; Han J; Li X; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):410-2. PubMed ID: 15625846
[TBL] [Abstract][Full Text] [Related]
7. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells.
Li C; Yan W; Hao Y; Han M; Qiu L; Liu H; Han J; Li X; Feng S
Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642
[TBL] [Abstract][Full Text] [Related]
8. [Effects of recombinant human interleukin-10 on tumor necorsis factor-alpha-induced adventitial fibroblast proliferation in vitro].
Ouyang P; Meng SR; Liu YB; Xu DL; Lai WY; Peng LS; Xu AL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):50-2. PubMed ID: 14724096
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentiation-inducing activity produced by human bone marrow stromal cell line LP101.
Hiramoto M; Kawakami Y; Nabeshima R; Shima D; Handa H; Aizawa S
Int J Mol Med; 2004 Nov; 14(5):867-72. PubMed ID: 15492858
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant human interleukin-10 inhibits vascular smooth muscle cell proliferation induced by TNF-alpha].
OuYang P; Peng LS; Yang H; Wu WY; Xu AL
Sheng Li Xue Bao; 2002 Feb; 54(1):79-82. PubMed ID: 11930247
[TBL] [Abstract][Full Text] [Related]
11. Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonskaca E; Puzewska W; Marcinczyk M; Jablonski J
Mediators Inflamm; 2003 Dec; 12(6):355-9. PubMed ID: 14668095
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application.
Charak BS; Areman EM; Dickerson SA; Choudhary GD; Sacher R; Kotula PL; Brown EG; Mazumdar A
Bone Marrow Transplant; 1993 Feb; 11(2):147-54. PubMed ID: 8435664
[TBL] [Abstract][Full Text] [Related]
13. Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease.
Schmit A; Carol M; Robert F; Bontems P; Houben JJ; Van Gossum A; Goldman M; Mascart F
Eur Cytokine Netw; 2002; 13(3):298-305. PubMed ID: 12231473
[TBL] [Abstract][Full Text] [Related]
14. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3.
Schweiger A; Stern D; Lohman IC; Baldini M; Martinez FD; Halonen M
J Allergy Clin Immunol; 2001 Mar; 107(3):505-10. PubMed ID: 11240952
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
16. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.
Hara T; Ando K; Tsurumi H; Moriwaki H
Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-suppression effect of polyactin A combined with GM-CSF, TNF-alpha and IL-4 on cord blood mononuclear cells].
Dong WJ; Hu HT; Gong HL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):553-7. PubMed ID: 16320587
[TBL] [Abstract][Full Text] [Related]
18. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells].
Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754
[TBL] [Abstract][Full Text] [Related]
19. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.
Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R
Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908
[TBL] [Abstract][Full Text] [Related]
20. In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules.
Ampel NM
Cell Immunol; 1994 Jan; 153(1):248-55. PubMed ID: 8287491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
